Substance abuse, temperament and suicide risk: Evidence from a case-control study

Journal of Addictive Diseases

Volumn 28, Issue 1, 2009, Pages 13-20

  Pompili, Maurizio ^a,b   Innamorati, Marco ^a   Lester, David ^c   Akiskal, Hagop S ^d,e   Rihmer, Zoltan ^f,g   Casale, Antonio Del ^a   Amore, Mario ^h   Girardi, Paolo ^a   Tatarelli, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MCLEAN HOSPITAL   (United States)

^c RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

^d International Mood Center   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^g SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^h UNIVERSITY OF PARMA   (Italy)

Author keywords

Bipolar disorder; Drug abuse disorders; Major depressive disorder; Schizophrenia; Suicide; Temperaments

Indexed keywords

ADULT; ARTICLE; BIPOLAR II DISORDER; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MENTAL DISEASE; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SUBSTANCE ABUSE; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; TEMPERAMENT;

ADULT; AGED; CASE-CONTROL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED; TEMPERAMENT;

EID: 60749104179     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880802544757     Document Type: Article

References (49)

1. Cuffel BJ. Comorbid substance use disorder: prevalence, patterns of use, and course. New Dir Ment Health Serv. 1996;70:93-106.
2. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264:2511-8.
3. RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999; 50:1427-34.
4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19.
5. Havassy BE, Alvidrez J, Owen KK. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry. 2004;161:139-45.
6. SAMHSA. Co-Occurring Major Depressive Episode (MDE) and Alcohol Use Disorder among Adults. The NSDUH Report. 2007.
7. Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance, R. Double jeopardy: schizophrenia and substance use. Am J Drug Alcohol Abuse. 2000;26:343-53.
8. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull. 1998;24:443-55.
9. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res. 2004;67:157-66.
10. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry. 1999;60:733-40.
11. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord. 2005;87:43-55.
12. Alpert JE, Fava M, Uebelacker LA, Nierenberg AA, Pava JA, Worthington JJ 3rd, et al. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry. 1999;46:202-11.
13. Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olie JP, Loo H, et al. Cannabis et schizophrenie: donnees cliniques et socio-demographiques. Encephale. 2003;29:11-17.
14. Lin CC, Bai YM, Hu PG, Yeh HS. Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital. Gen Hosp Psychiatry. 1998;20:98-101.
15. Coodin S, Staley D, Cortens B, Desrochers R, McLandress S. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry. 2004;49:145-8.
16. Ries RK, Yuodelis-Flores C, Comtois KA, Roy-Byrne PP, Russo JE. Substance-induced suicidal admissions to an acute psychiatric service: Characteristics and outcomes. J Subst Abuse Treat. 2008;34:72-9.
17. Pelkonen M, Marttunen M, Laippala P, Lonnqvist J. Factors associated with early dropout from adolescent psychiatric outpatient treatment. J Am Acad Child Adolesc Psychiatry. 2000;39:329-36.
18. Hunt IM, Kapur N, Robinson J, Shaw J, Flynn S, Bailey H, et al. Suicide within 12 months of mental health service contact in different age and diagnostic groups: National clinical survey. Br J Psychiatry. 2006;188:135-42.
19. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner R, Burns BJ. Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Soc Psychiatry Psychiatr Epidemiol. 1998;33(Suppl 1):S75-80.
20. Serper MR, Goldberg BR, Herman KG, Richarme D, Chou J, Dill CA, et al. Predictors of aggression on the psychiatric inpatient service. Compr Psychiatry. 2005;46:121-7.
21. Pencer A, Addington J. Substance use and cognition in early psychosis. J Psychiatry Neurosci. 2003;28:48-54.
22. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci. 1997;22:99-104.
23. Office of Applied Studies. Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults. OAS Report, 2006.
24. Potash JB, Kane HS, Chiu YF, Simpson SG, MacKinnon DF, McInnis MG, et al. Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships. Am J Psychiatry. 2000;157:2048-50.
25. Kim JH, Kim D, Park SH, Lee HB, Chung EK. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse. J Nerv Ment Dis. 2007;195:622-4.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 2000.
27. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33.
28. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord. 2005;85:3-16.
29. Derogatis LR. SCL-90-R: Adminstration, Scoring and Procedures Manual-II. Towson: Clinical Pychometric Research, 1983.
30. Rutz W, von Knorring L, Pihlgren H, Rihmer Z, Walinder J. Prevention of male suicides: lessons from Gotland study. Lancet. 1995;345:524.
31. Walinder J, Rutzt W. Male depression and suicide. Int Clin Psychopharmacol. 2001;16 Suppl 2:S21-24.
32. Rutz W. Improvement of care for people suffering from depression: the need for comprehensive education. Int Clin Psychopharmacol. 1999;14(Suppl 3):S27-33.
33. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42:861-5.
34. Akiskal HS, Placidi GF, Maremmani I, Signoretta S, Liguori A, Gervasi R, et al. TEMPS-I: delineating the most discriminant traits of the cyclothymic, depressive, hyperthymic and irritable temperaments in a nonpatient population. J Affect Disord. 1998;51:7-19.
35. Pompili M, Girardi P, Tatarelli R, Iliceto P, De Pisa E, Tondo L, et al. TEMPS-A (Rome): Psychometric validation of affective temperaments in clinically well subjects inmidand south Italy. J Affect Disord. 2008;107:63-75.
36. Moller-Leimkuhler AM, Bottlender R, Strauss A, Rutz W. Is there evidence for a male depressive syndrome in inpatients with major depression? J Affect Disord. 2004;80:87-93.
37. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990;147:190-5.
38. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society, Series B. 1995;57:289-300.
39. Pompili M, Rihmer Z, Akiskal HS, Innamorati M, Iliceto P, Akiskal KK, et al. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients. Psychopathology. 2008;41:313-21.
40. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity. J Affect Disord. 2003;73:49-57.
41. Kochman FJ, Hantouche EG, Ferrari P, Lancrenon S, Bayart D, Akiskal HS. Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder. J Affect Disord. 2005;85:181-9.
42. Rihmer A, Rózsa S, Rihmer Z, Gonda X, Akiskal KK, Akiskal HS. Affective temperament-types and suicidal behaviour. Eur Psychiatry. 2007;22:s244.
43. Lewis CE, Robins L, Rice J. Association of alcoholism with antisocial personality in urban men. J Nerv Ment Dis. 1985;173:166-74.
44. Tarter RE, Blackson T, Brigham J, Moss H, Caprara GV. The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse. Drug Alcohol Depend. 1995;39:253-61.
45. Arato M, Demeter E, Rihmer Z, Somogyi E. Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr Scand. 1988;77:454-6.
46. Rihmer Z, Kiss K. Bipolar disorders and suicidal behaviour. Bipolar Disord. 2002;4(Suppl 1):21-5.
47. Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am. 1999; 2:667-73, ix-x.
48. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976;11:31-42.
49. Rihmer Z. Suicide risk in mood disorders. Curr Opin Psychiatry. 2007;20:17-22.